KRKA revenue breakdown by business segment: 97.5% from PHARMACEUTICAL DIVERSIFIED and 2.5% from Other
KRKA revenue breakdown by geographic segment: 5.7% from SOUTH-EAST EUROPE, 35.1% from EASTERN EUROPE, 54.3% from EUROPEAN UNION and 5.0% from Other
EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Revenue | 1.3b | 1.5b | 1.5b | 1.6b |
Cost of goods sold | (450.5m) | (534.8m) | (511.9m) | (565.8m) |
Gross profit | 892.0m | 971.0m | 1.0b | 1.0b |
R&D expense | (130.7m) | (152.4m) | (153.4m) | (154.6m) |
Operating expense total | (550.8m) | (586.9m) | (531.1m) | (547.8m) |
Depreciation and amortization | (110.6m) | (111.2m) | (111.7m) | (108.8m) |
EBITDA | 341.1m | 384.1m | 501.5m | 462.5m |
EBIT | 236.0m | 274.2m | 390.7m | 354.8m |
Interest expense | (5.3m) | (2.9m) | (2.0m) | (1.6m) |
Interest income | 470.0k | 1.3m | 2.1m | 820.0k |
Pre tax profit | 202.6m | 284.4m | 339.0m | 362.4m |
Income tax expense | (28.6m) | (40.1m) | (50.0m) | (54.3m) |
Net Income | 174.0m | 244.3m | 288.9m | 308.2m |
EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 378.5m | 382.9m | 329.4m | 462.9m | 340.9m | 356.4m | 395.8m | 412.8m | 368.0m | 432.5m |
Cost of goods sold | (135.3m) | (137.1m) | (119.5m) | (159.2m) | (105.4m) | (110.2m) | (140.5m) | (152.9m) | (137.1m) | (156.3m) |
Gross profit | 246.9m | 248.1m | 212.0m | 306.9m | 238.7m | 245.4m | 257.2m | 264.1m | 230.6m | 277.9m |
R&D expense | (36.5m) | (38.0m) | (36.3m) | (37.6m) | (36.2m) | (38.2m) | (39.1m) | (36.5m) | (37.5m) | (41.8m) |
Operating expense total | (146.9m) | (138.4m) | (147.5m) | (144.9m) | (127.8m) | (133.7m) | (133.6m) | (132.7m) | (132.9m) | (144.3m) |
Depreciation and amortization | (27.7m) | (27.5m) | (27.5m) | (28.1m) | (28.1m) | (27.6m) | (27.3m) | (27.2m) | (26.9m) | (26.3m) |
EBITDA | 99.9m | 109.8m | 64.5m | 162.0m | 110.9m | 111.6m | 123.6m | 131.5m | 97.7m | 133.6m |
EBIT | 72.2m | 82.3m | 37.0m | 133.9m | 82.8m | 84.1m | 96.3m | 104.2m | 70.8m | 107.3m |
Interest expense | (824.0k) | (804.0k) | (747.0k) | (505.0k) | (468.0k) | (491.0k) | (333.0k) | (345.0k) | (377.0k) | (880.0k) |
Interest income | 133.0k | 187.0k | 735.0k | 148.0k | 109.0k | 82.0k | 118.0k | 136.0k | 216.0k | 558.0k |
Pre tax profit | 81.5m | 82.4m | 37.6m | 101.2m | 89.1m | 60.0m | 101.1m | 106.1m | 72.9m | 105.6m |
Income tax expense | (11.2m) | (12.8m) | (5.6m) | (16.0m) | (14.0m) | (10.1m) | (14.8m) | (15.0m) | (10.2m) | (14.9m) |
Net Income | 70.3m | 69.6m | 32.0m | 85.2m | 75.1m | 49.9m | 86.4m | 91.1m | 62.7m | 90.7m |
EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Cash | 117.8m | 218.7m | 313.6m | 159.8m |
Accounts Receivable | 438.3m | 434.7m | 383.6m | 467.8m |
Inventories | 365.1m | 421.6m | 453.7m | 455.7m |
Current Assets | 974.3m | 1.1b | 1.2b | 1.5b |
PP&E | 839.4m | 862.8m | 807.8m | 774.4m |
Goodwill | 42.6m | 42.6m | 42.6m | 42.6m |
Total Assets | 2.0b | 2.2b | 2.2b | 2.5b |
Accounts Payable | 136.8m | 138.6m | 107.1m | 130.0m |
Short-term debt | 2.8m | 2.7m | 3.4m | |
Current Liabilities | 321.7m | 356.2m | 310.9m | 455.9m |
Long-term debt | 10.2m | 9.1m | 8.7m | |
Non-Current Liabilities | 123.1m | 160.9m | 172.8m | 162.7m |
Total Debt | 13.0m | 11.8m | 12.2m | |
Total Liabilities | 444.8m | 517.1m | 483.7m | 618.6m |
Common Stock | 54.7m | 54.7m | 54.7m | 54.7m |
Retained Earnings | 1.4b | 1.6b | 1.7b | 1.8b |
Total Equity | 1.5b | 1.7b | 1.8b | 1.9b |
EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Cash | 184.9m | 230.0m | 189.8m | 274.1m | 358.3m | 265.6m | 412.4m | 459.6m | 348.6m | 205.6m |
Accounts Receivable | 471.2m | 475.6m | 424.2m | 509.8m | 408.4m | 358.6m | 411.1m | 463.5m | 464.4m | 485.7m |
Inventories | 372.8m | 380.0m | 408.3m | 409.5m | 454.4m | 454.1m | 441.8m | 444.4m | 435.4m | 469.5m |
Current Assets | 1.1b | 1.1b | 1.1b | 1.3b | 1.3b | 1.2b | 1.3b | 1.4b | 1.4b | 1.5b |
PP&E | 868.5m | 872.2m | 870.8m | 832.1m | 826.6m | 812.6m | 782.9m | 791.6m | 783.3m | 764.7m |
Goodwill | 42.6m | 42.6m | 42.6m | 42.6m | 42.6m | 42.6m | 42.6m | 42.6m | 42.6m | 42.6m |
Total Assets | 2.1b | 2.2b | 2.1b | 2.3b | 2.3b | 2.2b | 2.3b | 2.4b | 2.3b | 2.6b |
Accounts Payable | 139.0m | 121.4m | 124.9m | 119.6m | 115.4m | 112.4m | 104.7m | 111.2m | 105.7m | 130.2m |
Short-term debt | 2.1m | 1.9m | 1.9m | 2.6m | 2.6m | 2.7m | 3.0m | 3.2m | 3.2m | 3.4m |
Current Liabilities | 348.4m | 346.4m | 361.9m | 394.7m | 362.5m | 326.0m | 310.5m | 321.4m | 320.1m | 479.8m |
Long-term debt | 22.1m | 21.6m | 21.0m | 9.7m | 9.3m | 9.3m | 9.3m | 9.3m | 8.8m | 8.4m |
Non-Current Liabilities | 156.1m | 155.8m | 153.6m | 161.2m | 161.3m | 162.2m | 173.5m | 172.9m | 173.0m | 162.6m |
Total Debt | 24.2m | 23.5m | 22.9m | 12.3m | 11.9m | 12.0m | 12.3m | 12.5m | 12.0m | 11.8m |
Total Liabilities | 504.5m | 502.2m | 515.5m | 555.9m | 523.9m | 488.2m | 484.0m | 494.3m | 493.1m | 642.3m |
Common Stock | 54.7m | 54.7m | 54.7m | 54.7m | 54.7m | 54.7m | 54.7m | 54.7m | 54.7m | 54.7m |
Additional Paid-in Capital | 105.9m | |||||||||
Retained Earnings | 1.5b | 1.6b | 1.5b | 1.6b | 1.7b | 1.6b | 1.8b | 1.9b | 1.8b | 1.9b |
Total Equity | 1.6b | 1.7b | 1.6b | 1.7b | 1.8b | 1.7b | 1.8b | 1.9b | 1.8b | 2.0b |
EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Net Income | 174.0m | 244.3m | 288.9m | 308.2m |
Depreciation and Amortization | 110.6m | 111.2m | 111.7m | 108.8m |
Accounts Receivable | 61.9m | (4.2m) | 55.7m | (83.7m) |
Inventories | (54.5m) | (56.4m) | (32.1m) | (2.0m) |
Accounts Payable | 29.6m | 11.2m | (33.7m) | 45.2m |
Cash From Operating Activities | 290.0m | 349.5m | 360.8m | 386.1m |
Cash From Investing Activities | (114.4m) | (124.8m) | (109.6m) | (372.6m) |
Short-term Borrowings | 3.0k | |||
Long-term Borrowings | (3.0k) | |||
Dividends Paid | (92.8m) | (101.7m) | (133.3m) | (155.9m) |
Cash From Financing Activities | (102.6m) | (124.3m) | (154.6m) | (169.8m) |
Net Change in Cash | 71.9m | 100.9m | 94.9m | (153.7m) |
EUR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 70.3m | 139.9m | 171.9m | 85.2m | 160.3m | 210.1m | 86.4m | 177.4m | 240.1m | 90.7m |
Depreciation and Amortization | 27.7m | 55.2m | 82.7m | 28.1m | 56.2m | 83.8m | 27.3m | 54.5m | 81.4m | 26.3m |
Accounts Receivable | (40.0m) | (41.7m) | 9.4m | (68.0m) | 27.1m | 81.4m | (27.2m) | (85.7m) | (84.5m) | (17.6m) |
Inventories | (7.6m) | (14.8m) | (43.2m) | 12.1m | (32.9m) | (32.5m) | 11.9m | 9.3m | 18.2m | (13.8m) |
Accounts Payable | 19.5m | 1.2m | 18.6m | 24.2m | 1.0m | (25.2m) | 4.8m | 2.0m | 10.2m | 14.7m |
Cash From Operating Activities | 91.9m | 177.7m | 276.7m | 88.4m | 208.0m | 292.1m | 106.9m | 173.3m | 274.2m | 82.8m |
Cash From Investing Activities | (19.6m) | (54.8m) | (88.9m) | (26.6m) | (49.9m) | (95.4m) | (4.9m) | (18.7m) | (77.3m) | (42.7m) |
Short-term Borrowings | (3.0k) | |||||||||
Long-term Borrowings | (757.0k) | (1.5m) | (2.2m) | (1.5m) | (2.3m) | |||||
Dividends Paid | (2.0k) | (2.0k) | (101.7m) | 68.0k | (133.3m) | (9.0k) | (155.9m) | (19.0k) | ||
Cash From Financing Activities | (5.3m) | (9.6m) | (116.8m) | (5.7m) | (17.7m) | (148.4m) | (3.7m) | (9.2m) | (163.9m) | (457.0k) |
Net Change in Cash | 67.1m | 112.2m | 72.0m | 55.5m | 139.7m | 46.9m | 98.8m | 146.0m | 35.1m | 45.7m |
EUR | FY, 2018 |
---|---|
Revenue/Employee | 126.1k |